Introducing Medical Advisor: An van Es-Johansson, MD
July 2025
We’re proud to welcome An van Es-Johansson, MD as our Medical Advisor at Cori Clinical.
An brings a rare combination of vast clinical development experience, board-level strategic insight, and leadership across pharma and biotech. She currently advises start up biotech companies and is Director of the Board of Plus Therapeutics (PSTV, Nasdaq) and Savara (SVRA, Nasdaq).
Earlier in her career, An held senior roles at Sobi, Roche, Eli Lilly, Alzecure and Active Biotech, and served on the Scientific Advisory Board of Uppsala BIO for over a decade. She’s led Clinical Development, Medical Affairs and Business Development for both global pharma and emerging biotechs, with a focus on translating science into patient impact with focus on rare diseases.
Her insight will help guide Cori Clinical as we build AI-driven tools to support clinical development, starting with the complex workflows from protocol to First Patient In to regulatory filings and approvals.
We’re grateful for her belief in our mission, and thrilled to have her on board.